首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1624974

全球臉部注射劑市場規模（按產品、應用、地區、範圍和預測）

Global Facial Injectables Market Size By Product (Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA)), By Application (Therapeutics, Aesthetics), By Geographic Scope And Forecast

出版日期: 2024年11月19日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

臉部注射劑的市場規模及預測

2021 年臉部注射劑市場規模價值 5,746,0.5 億美元，預計到 2030 年將達到 23,448,2.3 億美元，2023 年至 2030 年的複合年增長率為 16.91%。臉部填充物最常見的用途是減少老化的早期跡象並增強美感。膠原蛋白、玻尿酸、聚合物和肉毒桿菌毒素是最常用的臉部注射劑。臉部注射療法在減少皮膚皺紋、使皮膚光滑、豐唇、去除皺紋、治療痤瘡、治療疤痕等方面的流行，正在推動臉部注射劑的市場應用，我們正在這樣做。在即將進行的研究中，美國 FDA 正在考慮批准使用臉部填充物治療聲帶麻痺，這預計將促進臉部填充物市場的成長。

臉部填充劑的全球市場定義

真皮填充劑是另一個臉部注射劑的名稱。臉部注射劑包括膠原蛋白、羥基磷灰石鈣和透明質酸類治療，可發揮多種功效，包括去除或減少皺紋、豐唇、提升疤痕和減少軟組織體積。臉部填充物用於填充目標區域，有助於減少臉部皺紋和瑕疵。抗皺注射劑可以放鬆引起皺紋的肌肉，而真皮填充劑可以減少皺紋並增加臉頰和嘴唇的體積。

皮膚填充劑直接注射到皺紋中，而抗皺紋注射劑則放鬆產生皺紋的肌肉。填充劑由糖分子或透明質酸、膠原蛋白（從豬、牛、屍體中提取或在實驗室合成）、患者的脂肪和合成聚合物組成。羥基磷灰石鈣、聚醯胺、聚丙烯酸酯和聚乳酸就是後者的例子。 Artiste 輔助注射系統於 2012 年引進美國市場，用於輔助注射真皮填充劑。

透過控制臨床醫生使用填充物填充嘴唇和鬢角的速率，注射器裝置可以減少患者的不適和不良事件。瘀青、發紅、不適和搔癢都是皮膚填充手術失敗的常見副作用。感染和過敏反應是造成疤痕或腫瘤的不常見原因。在極少數情況下，曾報告過因眼靜脈或視網膜靜脈逆行（突然）栓塞而促使失明等嚴重副作用。

該產業正在利用技術突破。目前正在利用先進的技術創新開發抗氧化皮膚貼片。貼片底部採用微針穿透皮膚，使抗氧化劑滲透到皮膚深層。這些貼片可能是一種更好、更快的在家中舒緩和提亮皮膚的方法。這款貼片富含抗氧化劑，可充分發揮其潛力，為我們提供撫平皺紋、亮白肌膚的功效。這為該行業帶來了各種未來機會。

臉部填充劑全球市場概況

人們發現，臉部注射劑市場正在蓬勃發展，規模也不斷成長。非手術市場治療、臉部注射填充劑和減少皺紋注射均增加了三倍。預計預測期內非侵入性美容手術將推動市場成長。污染和多種生活方式的選擇會促使皮膚損傷，從而在預測期內增加需求。膠原纖維、透明質酸填充劑、合成填充劑等可用作臉部注射。這款乳霜可以滋潤和強化皮膚，同時保護皮膚免受紫外線的傷害並最大限度地減少其有害影響。

臉部注射劑市場受上述所有標準驅動。此外，整形外科醫生及其網路的崛起推動了對整容手術的需求，從而增加了對臉部注射劑的需求。 FDA 也批准包括牙醫在內的其他從業人員在其診所中使用臉部填充劑。由於牙醫會遇到許多在牙科治療後需要進行臉部重塑的患者，因此他們現在可以進行臉部注射手術。因此，臉部注射劑市場可能會得到發展。

此外，治療方法和材料的進步以及患者人口結構的變化正在幫助醫生和皮膚科醫生治療各種面部區域。這些創新有助於醫生和皮膚科醫生為患者制定個人化治療方案，使使用組合產品獲得更好效果變得更加容易，並推動了全球臉部注射劑的成長。預計所有這些因素都將促進市場未來的成長。與 HA（透明質酸）和 BoNTA（A 型肉毒桿菌）填充劑等放大產品結合使用，可改善效果，尤其是在下臉部過程中。

這也有助於擴大全球臉部填充劑市場。臉部注射劑的生產能力、關鍵市場參數、年成長率以及製造商市場佔有率都是影響行業機會的方面。由於對嚴格規定、物品限制以及皮疹和發紅等皮膚問題的擔憂，其增長受到限制。與美學應用相比，未來幾年市場擴張預計還會受到多種市場限制的阻礙。填充劑價格過高，限制了擴張，從而縮小了市場規模。皮膚填充劑的不良反應也是限制臉部注射劑業務規模的一個主要問題。

Facial Injectables Market size was valued at USD 5,746.05 Million in 2021 and is projected to reach USD 23,448.23 Million by 2030 , growing at a CAGR of 16.91% from 2023 to 2030. The most common uses for facial injectables are to alleviate early indications of aging and to enhance aesthetic appeal. Collagens, hyaluronic acids, polymers, and botulinum toxins are some of the most regularly utilized facial injectables. The popularity of face injectable treatment for skin fold reduction, skin smoothening, lip augmentation, wrinkle elimination, acne treatment, scar treatment, and other applications is driving the market adoption of facial injectables. In the following study, the usage of face Injectables for the treatment of paralyzed vocal cords is being considered by the US FDA for approval, which is projected to boost the Facial Injectables Market's growth.

Global Facial Injectables Market Definition

Dermal fillers are another name for facial injectables. Facial injectables include collagen, calcium hydroxyapatite, and hyaluronic acid-based treatments that rejuvenate the facial skin by performing a variety of tasks such as wrinkle removal and reduction, lip enhancement, scar elevating, and soft tissue volume reduction. Filling the target area with facial injectables soothes wrinkles and scars on the face. Anti-wrinkle injections relax the muscles that produce wrinkles, while dermal fillers minimize wrinkles and add volume to the cheeks and lips.

Dermal fillers are injected directly into the wrinkles, while anti-wrinkle injections relax the muscles that generate wrinkles. Fillers are constructed of sugar molecules or hyaluronic acids, collagens (that can come from swine, cows, and cadavers, or be synthesized in a lab), the patient's fat, and synthetic polymers. Calcium hydroxyapatite, polyamide, polyacrylate, and polylactic acid are examples of the latter. The "Artiste Assisted Injection System" was introduced to the US market in 2012 to help in dermal filler distribution.

The injecting device can reduce patient discomfort and adverse events by managing the rate of filling of the injection which is being used by the physician to fill in the lip and frown lines. Bruising, redness, discomfort, and itching are all frequent side effects of a botched dermal filler operation. Infection or allergic reactions are fewer common causes of scarring and tumors. Serious side effects such as blindness from retrograde (abrupt) embolization of the ophthalmic and retinal veins have been reported on a more uncommon basis.

The industry makes use of technological breakthroughs. Antioxidant epidermal patches are now being developed at a high level of innovation. The use of a microneedle on the bottom of the patches penetrates the skin, allowing antioxidants to go deep into the skin. These patches could be a better, faster approach to calming and lightening your skin at home. Patches with better antioxidant penetration will reach their full potential, allowing them to give the wrinkle-smoothing and skin-brightening benefits we want. Providing a variety of future chances for the sector.

Global Facial Injectables Market Overview

The sector has been discovered to be flourishing, with an increase in the size of the Facial Injectables Market. Non-surgical market treatments, facial injectable fillers, and wrinkle relaxer injectables have all seen a three-fold increase. Non-invasive aesthetic procedures will grow the market during the projection period. Skin damage is caused by pollution and numerous lifestyle choices, which drive up demand during the projection period. Collagen fibers, hyaluronic acid fillers, and synthetic fillers are used to make facial injectables. This cream moisturizes and enhances your skin while also protecting it from UV damage and having minimal negative effects.

The market for face injectables is driven by all of the aforementioned criteria. Furthermore, the growing number of plastic surgeons and their networks is driving demand for aesthetic procedures, which is boosting demand for face injectables. There was also FDA authorization for other practitioners, including dentists, to utilize face Injectables in their clinics. Dentists can now perform face injectable procedures because they encounter many patients requiring facial transformation after dental treatments. The market for facial injectables is likely to develop as a result of this.

In addition, advances in treatments and materials, as well as changes in patient demographics, are assisting physicians and dermatologists in treating diverse facial areas. These innovations help physicians and dermatologists create customized treatments for patients and make it easier to use combination products to achieve better outcomes, propelling the worldwide Facial Injectables Market. All of these factors are expected to contribute to the market's future growth. Amplified products like HA (Hyaluronic Acid) and BoNTA (Botulinum Toxin Type A) fillers are used in conjunction to improve outcomes, especially in the lower facial processes.

This also fuels the worldwide Facial Injectables Market's expansion. The capacity of face injectables, major market parameters, year-over-year growth rate, and manufacturer market share are all aspects that influence the industry's opportunities. The growth is restricted by tight regulatory concerns and limits on the items, as well as skin problems such as rashes and redness. Rather than aesthetic applications, the market's expansion will be hampered by several market-hindering factors in the future projection year. Filler prices are too high, limiting expansion and, as a result, market size. The negative effects of dermal fillers are also a major issue limiting the size of the facial injectable business.

Global Facial Injectables Market Segmentation Analysis

The Global Facial Injectables Market is segmented on the basis of Product, Application, and Geography.

Facial Injectables Market, By Product

Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Collagen
Hyaluronic Acid (HA)
Polymer Fillers

Based on Product, the market is bifurcated into Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Collagen, Hyaluronic Acid (HA), and Polymer Fillers. The hyaluronic acid segment dominated the market, and it is predicted to increase at a healthy rate over the next few years. The increasing use of hyaluronic acid in the cosmetics industry is likely to fuel growth. Because of its high-water retention qualities and low allergic reactions, hyaluronic acid has become a staple in cosmetics. Hyaluronic acid segment growth includes a moisture-binding feature that helps preserve and enhance the vital moisture held to account for the plumpness of the facial skin. The segment's rise is fuelled by growing demands for cosmetic surgeries and an increase in the number of facial surgeries done.

Facial Injectables Market, By Application

Therapeutics
Aesthetics

Based on Application, the market is bifurcated into Therapeutics and Aesthetics. Increasing use of facial injectables for aesthetic procedures such as treatment of parentheses lines, wrinkles on the face, lip lines, lip augmentation, lip border restoration, perioral lines, crow's feet lines, frown lines, glabellar lines, filling furrows (deep wrinkles), periorbital wrinkles, superficial lines, acne scars, tear troughs, marionette lines, lipoatrophy of the face, nasopharyngeal. In the future years, demand for facial injectables for cosmetic purposes is predicted to rise due to a growing interest in physical appearance and income growth among middle-class people in developing nations such as India.

Facial Injectables Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Regional Analysis, the Global Facial Injectables Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America led the market in 2020, accounting for more than 41.0 percent of total sales. The high elderly population in the United States and Canada is expected to drive demand for face injectables over the projected period. Botox injections were discovered to have jumped by 845 percent. As a result, in the coming years, North America is likely to be a major income generator for facial injectables. The Asia Pacific market is expected to increase at a quick rate. Among the countries that help the region are India, Australia, and South Korea. In these developing countries, a growing emphasis on physical attractiveness is projected to drive the desire for facial injectable treatments. India is expected to be the largest economy in the world by 2050.

Key Players

The "Global Facial Injectables Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
Suneva Medical Inc., ALLERGAN, Bloomage BioTechnology Corporation Limited, Ipsen, Merz Pharma, Anika Therapeutics Inc., Medytox Inc, Galderma S.A, Prollenium Medical Technologies Inc, Sinclair Pharma.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

The International Society of Aesthetic Plastic Surgery in the United States came in first for non-surgical product discovery. Botulinum toxin and hyaluronic acid were the most well-known injectables identified so far.
In June 2020, For persons above the age of 21, to reduce wrinkles The FDA granted Allergan Aesthetics approval to develop a variety of cosmetic products. It also acquired FDA approval for the use of hyaluronic acid gel for cheeks to treat age-related disorders from the Food and Drug Administration.
In August 2018, Antares Pharma and Pfizer Inc. collaborated to develop the rescue pen, an injectable medication device.
HUMIRA Pen, face injectable fillers, is utilized for human anti-tumor necrosis factor-alpha monoclonal antibodies in the Facial Injectables Market forecast. Patients with rheumatoid arthritis use this injectable medicine, which increases its market demand.

1 INTRODUCTION OF GLOBAL FACIAL INJECTABLES MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL FACIAL INJECTABLES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model

5 GLOBAL FACIAL INJECTABLES MARKET, BY PRODUCT

5.1 Overview
5.2 Botulinum Toxin Type A
5.3 Calcium Hydroxylapatite (CaHA)
5.4 Collagen
5.5 Hyaluronic Acid (HA)
5.6 Polymer Fillers

6 GLOBAL FACIAL INJECTABLES MARKET, BY APPLICATION

6.1 Overview
6.2 Therapeutics
6.3 Aesthetics

7 GLOBAL FACIAL INJECTABLES MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East & Africa

8 GLOBAL FACIAL INJECTABLES MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Suneva Medical, Inc.
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 ALLERGAN
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Bloomage BioTechnology Corporation Limited
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Ipsen
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Merz Pharma
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Anika Therapeutics, Inc.
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Medytox, Inc.
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Galderma S.A.
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Prollenium Medical Technologies Inc.
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Sinclair Pharma
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments